Australia is closely awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://esmeeaser754378.wikifrontier.com/9218947/retatrutide_australia_a_new_hope_for_weight_management